Clinical Trial Update: Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on an early-phase safety and feasibility study of intranasal mesenchymal trophic factor (MTF) for treating asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Intranasal Mesenchymal Trophic Factor (MTF) (mesenchymal trophic factor)

Snippet

Sponsor: Translational Biosciences | Conditions: Asthma | Phase 1, Phase 2 | Status: UNKNOWN